Become a client

Are you a client? You should contact your private banker. 
You are not a client but would like to have more information about Societe Generale Private Banking? Please fill in the form below.

Local contacts

France: +33 (0)1 53 43 87 00 (9am - 6pm)
Luxembourg: +352 47 93 11 1 (8:30am - 5:30pm)
Monaco: +377 97 97 58 00 (9/12am - 2/5pm)
Switzerland: Geneva +41 22 819 02 02
& Zurich +41 44 218 56 11 (8:30am - 5:30pm)

You would like to contact us about the protection of your personal data?

Please contact the Data Protection Officer of Societe Generale Private Banking France by sending an email to the following address: protectiondesdonnees@societegenerale.fr.

Please contact the Data Protection Officer of Societe Generale Luxembourg by sending an email to the following address: lux.dpooffice@socgen.com.

For customers residing in Italy, please contact BDO, the external provider in charge of Data Protection, by sending an email to the following address: lux.dpooffice-branch-IT@socgen.com

Please contact the Data Protection Officer of Societe Generale Private Banking Monaco by sending an email to the following address: list.mon-privmonaco-dpo@socgen.com

Please contact the Data Protection Officer of Societe Generale Private Banking Switzerland by sending an email to the following address : ch-dataprotection@socgen.com

You need to make a claim?

Societe Generale Private Banking aims to provide you with the best possible quality of service. However, difficulties may sometimes arise in the operation of your account or in the use of the services made available to you.

Your private banker  is your privileged contact to receive and process your claim.

 If you disagree with or do not get a response from your advisor, you can send your claim to the direction  of Societe Generale Private Banking France by email to the following address: FR-SGPB-Relations-Clients@socgen.com or by mail to: 

Société Générale Private Banking France
29 boulevard Haussmann CS 614
75421 Paris Cedex 9

Societe Generale Private Banking France undertakes to acknowledge receipt of your claim within 10 (ten) working days from the date it is sent and to provide you with a response within 2 (two) months from the same date. If we are unable to meet this 2 (two) month deadline, you will be informed by letter.

In the event of disagreement with the bank  or of a lack of response from us within 2 (two) months of sending your first written claim, or within 15 (fifteen) working days for a claim about a payment service, you may refer the matter free of charge, depending on the nature of your claim, to:  

 

The Consumer Ombudsman at the FBF

The Consumer Ombudsman at the Fédération Bancaire Française (FBF – French Banking Federation) is competent for disputes relating to services provided and contracts concluded in the field of banking operations (e.g. management of deposit accounts, credit operations, payment services etc.), investment services, financial instruments and savings products, as well as the marketing of insurance contracts.

The FBF Ombudsman will reply directly to you within 90 (ninety) days from the date on which she/he receives all the documents on which the request is based. In the event of a complex dispute, this period may be extended. The FBF Ombudsman will formulate a reasoned position and submit it to both parties for approval.

The FBF Ombudsman can be contacted on the following website: www.lemediateur.fbf.fr or by mail at:

Le Médiateur de la Fédération Bancaire Française
CS 151
75422 Paris CEDEX 09

 

The Ombudsman of the AMF

The Ombudsman of the Autorité des Marchés Financiers (AMF - French Financial Markets Authority) is also competent for disputes relating to investment services, financial instruments and financial savings products.

For this type of dispute, as a consumer customer, you have therefore a choice between the FBF Ombudsman and the AMF Ombudsman. Once you have chosen one of these two ombudsmen, you can no longer refer the same dispute to the other ombudsman.

The AMF Ombudsman can be contacted on the AMF website: www.amf-france.org/fr/le-mediateur or by mail at:

Médiateur de l'AMF, Autorité des Marchés Financiers
17 place de la Bourse
75082 PARIS CEDEX 02
FRANCE


The Insurance Ombudsman

The Insurance Ombudsman is competent for disputes concerning the subscription, application or interpretation of insurance contracts.

The Insurance Ombudsman can be contacted using the contact details that must be mentioned in your insurance contract.

To ensure that your requests are handled effectively, any claim addressed to Societe Generale Luxembourg should be sent to:

Private banking Claims department
11, Avenue Emile Reuter
L-2420 Luxembourg

Or by email to clienteleprivee.sglux@socgen.com and for customers residing in Italy at societegenerale@unapec.it

The Bank will acknowledge your request within 10 working days and provide a response to your claim within 30 working days of receipt. If your request requires additional processing time (e.g. if it involves complex research), the Bank will inform you of this situation within the same 30-working day timeframe.

In the event that the response you receive does not meet your expectations, we suggest the following:

Initially, you may wish to contact the Societe Generale Luxembourg Division responsible for handling claims, at the following address:

Corporate Secretariat of Societe Generale Luxembourg
11, Avenue Emile Reuter
L-2420 Luxembourg

If the response from the Division responsible for claims does not resolve the claim, you may wish to contact Societe Generale Luxembourg's supervisory authority, the “Commission de Surveillance du Secteur Financier”/“CSSF” (Luxembourg Financial Sector Supervisory Commission):

By mail: 283, Route d’Arlon L-1150 Luxembourg
By email:
direction@cssf.lu

Any claim addressed to Societe Generale Private Banking Monaco should be sent by e-mail to the following address: servicequalite.privmonaco@socgen.com or by mail to our dedicated department: 

Societe Generale Private Banking Monaco
Middle Office – Service Réclamation 
11 avenue de Grande Bretagne
98000 Monaco

The Bank will acknowledge your request within 2 working days after receipt and provide a response to your claim within a maximum of 30 working days of receipt. If your request requires additional processing time (e.g. if it involves complex researches…), the Bank will inform you of this situation within the same 30-working day timeframe. 

In the event that the response you receive does not meet your expectations, we suggest to contact the Societe Generale Private Banking Direction that handles the claims by mail at the following address: 

Societe Generale Private Banking Monaco
Secrétariat Général
11 avenue de Grande Bretagne 
98000 Monaco

Any claim addressed to the Bank can be sent by email to:

sgpb-reclamations.ch@socgen.com
 

Clients may also contact the Swiss Banking Ombudsman: 

www.bankingombudsman.ch

 

Weekly Update - Still in the tunnel

This week’s announcement is clearly very encouraging. The partners’ vaccine has been tested on over 43,500 participants in phase 3 trials – the last phase before approval by health authorities – of whom 94 tested positive for COVID-19. Over 90% of the confirmed cases had received the placebo rather than the vaccine, suggesting an extremely high level of effectiveness – influenza vaccines are typically much less successful (see left-hand chart).

Moderna, another biotechnology company, also announced it will shortly commence interim analysis of data from phase 3 trials covering 30,000 people with over 53 confirmed cases. Hopes are high that this trial will also be successful given that the vaccine uses the same messenger RiboNucleic Acid (mRNA) technology as BioNTech’s. Moreover, there are other mRNA candidates in the pipeline from Germany’s CureVac and the Imperial College London. Among their advantages, mRNA vaccines are potentially faster to develop and easier to produce than traditional vaccines.

Of course, this does not mean that a vaccine will be available any time soon. The trials must be completed, and applications for approval lodged with the health authorities. Also, production will have to be ramped up – Pfizer and BioNTech estimate that they can have 50 million doses available by year-end and another 1.3 billion next year (and two doses are necessary for the vaccine to be effective). However, it has been estimated that global demand for vaccines could reach 10 to 15 billion doses. Moreover, BioNTech’s vaccine must be stored and shipped at ultra-low temperatures – approximately minus 75 degrees Celsius – which adds logistical complexity to supply chains.

All this means that governments are likely to be forced to keep restrictions and lockdowns in place for some time to come. Healthcare systems are already under pressure, with hospitalisation rates above or approaching April’s highs across Europe and the United States. Business confidence has dipped into contraction territory across continental Europe, driven by the slump in services, which are most directly hit by lockdowns. This means that much of Europe will slip back into recession in Q4, with meaningful recovery only likely towards the end of the winter season in the Northern Hemisphere.

The European Commission recently updated its economic forecasts for the European Union. 2020 will see the deepest recession in its history with the economy contracting by -7.4% over 2019, unchanged from the commission’s previous forecast. However, the recovery next year is likely to be slower than previously thought – up +4.1% rather than the +6.1% expansion it forecast in May. Importantly, this hinges on growth picking up in early 2021, which is by no means certain given the healthcare crisis.

However, this week’s announcement has brightened the longer-term outlook. The vaccines are likely to be reserved initially for healthcare professionals and the most vulnerable – the elderly, the obese etc. – which should relieve pressure on the health systems while vaccination begins for the broader population. Of course, many people may refuse vaccination, at least initially, but if compliance rates are sufficient – say above 40% – we should be able to look forward to some normalisation of economic activity from summer 2021.

Bottom line. The next few months are likely to prove challenging for businesses, depressing profitability and putting pressure on heavily indebted companies, especially in services. This means we should expect further bouts of volatility. However, the improved outlook from next spring will enable corporate management to begin to plan for the longer term. Financial markets tend to look forward and this welcome shift in prospects will help limit downside for risk assets in coming months.

Read full article​​​​​​​

Head of Investment Strategy Societe Generale Private Banking